FDA Offers Advice on Trial Design.
The FDA recently released a final guidance that outlines the specific situations in which placebos can be used in oncology clinical trials-and in which patients and investigators should be unblinded. Oncologists consider the guidance useful, but note that it largely aligns with how oncology trials are already conducted.